Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

Background Dialysis and kidney transplant patients are vulnerable populations for COVID-
19 related disease and mortality. Methods We conducted a prospective study exploring the …

Regular physical exercise is broadly recommended by current European and American
hypertension guidelines. It remains elusive, however, whether exercise leads to a reduction …

T cell immunity toward SARS-CoV-2 spike (S-), membrane (M-), and nucleocapsid (N-)
proteins may define COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive T …

The chimeric monoclonal anti-CD20 antibody rituximab targets and destroys B lymphocytes
and is used increasingly in the treatment of B-cell non-Hodgkin lymphoma. 1, 2 In spite of …

Objectives The RNA virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is responsible for coronavirus disease 2019 (COVID-19). Cell entry is mediated by the …

Chronic allograft injury (CAI) is the most common cause of graft failure after the first year of
transplantation. To date, only protocol biopsies can reveal subclinical disease. Transient …

Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare but life-threatening
condition. In 2018, the nanobody caplacizumab was approved for the treatment of adults …

Use of immune checkpoint inhibitors (ICIs) in solid organ transplant recipients (SOTRs) with
advanced skin cancers presents a significant clinical management dilemma. SOTRs and …

Results Median urinary calprotectin was 60.7 times higher in intrinsic AKI (1692 ng/ml) than
in prerenal AKI (28 ng/ml, p< 0.01). Urinary calprotectin in prerenal disease was not …